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C-type natriuretic peptide as a podocyte hormone and modula-
tion of its cGMP production by glucose and mechanical stress.
Background. High glucose and mechanical strain resulting
from capillary hypertension are relevant risk factors affecting
glomerular cells in diabetes. Altered activity of the natriuretic
peptide (NP) system acting via vasorelaxing cyclic guanosine
5′ monophosphate (cGMP) has been proposed to be one of
the reasons for diabetes-dependent impairment of kidney func-
tion. Podocytes possess the NP receptors (NPRs) coupled to
particular guanylyl cyclase. We investigated whether mechani-
cal stress and high ambient glucose influence cGMP generation
in podocytes stimulated with NPs. Additionally, the C-type na-
triuretic peptide (CNP) system has been characterized in these
cells.
Methods. Conditionally immortalized mouse podocytes were
stimulated with NP for 15 minutes and cGMP was deter-
mined by enzymatic immunoassay. The mRNA expression
for CNP and CNP-specific NPR-B was confirmed by reverse
transcriptase-polymerase chain reaction (RT-PCR). In addi-
tion, cGMP synthesis was measured in cells exposed to me-
chanical stress and to 30 mmol/L glucose for 3 days.
Results. Production of cGMP upon stimulation of the NPR-
B receptor with CNP and inhibition by an antagonist HS-142-1
was dose-dependent. RT-PCR showed that podocytes express
mRNA not only for NPR-B but also for CNP. Mechanical stress
reduced the cGMP response by 50%, both to atrial natriuretic
peptide (ANP) and to CNP. Conversely, upon high glucose,
the CNP-induced production of cGMP was elevated twofold
in stretched and in control cells. Furthermore, as compared to
ANP, stimulation with CNP caused a larger increase in cGMP
levels in stretched as well as in nonstretched cells.
Conclusion. Expression of CNP together with potent NPR-
B receptors suggests that in podocytes, CNP may act in an au-
tocrine and/or paracrine manner. Furthermore, in a diabetic
kidney, high glucose and mechanical stress may modulate the
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CNP-dependent cGMP production in podocytes in an opposite
manner.
The glomeruli are a major target for nitric oxide and
natriuretic peptides (NPs) in the kidney, and cyclic guano-
sine 5′ monophosphate (cGMP), a second messenger
for these factors, plays a prominent role in regulation
of glomerular function [1–3]. It has been shown previ-
ously that visceral epithelial cells (podocytes) contribute
to production of cGMP in glomeruli upon stimulation
with atrial natriuretic peptide (ANP) [4–6]. The presence
of contractile apparatus together with receptors for a va-
riety of vasoactive factors [7] suggests that in podocytes,
vasorelaxing cGMP may participate in modulating the ac-
tivity of constricting factors. However, to date, the data
on direct function of cGMP in podocytes are missing.
In diabetes, an elevated level of circulating NPs con-
tributes to microalbuminuria [8], which is associated with
podocyte impairment [9, 10]. Additionally, urinary cGMP
excretion is increased, which plays a potential role in the
development of glomerular hyperfiltration as well as in
the development of capillary hypertension [11–13]. In-
creased capillary wall tension, in turn, induces mechan-
ical load, which affects the structure and function of
glomerular cells, leading to their injury [14]. High ambient
glucose is another relevant factor contributing to the pro-
gression of glomerular impairment [15, 16]. Mechanical
stress, in turn, has been shown to potentiate glucose-
induced glomerular injury [17]. In vitro, both mechan-
ical stress [18–20] and high ambient glucose [21–23]
induce changes in podocyte morphology and expression
of various proteins, which may in vivo be associated with
modifications in the glomerular function. Moreover, in di-
abetic nephropathy, impaired podocytes are irreversibly
lost, which results in further development of nephron
damage [9].
Three types of natriuretic peptide receptor (NPR) are
found in the glomeruli: NPR-A and NPR-B, which are
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linked to the particulate guanylyl cyclase, and NPR-C, a
clearance receptor devoid of the GC activity [24–26]. De-
spite the lack of absolute specificity of NPs for particular
receptors, ANP predominantly binds to NPR-A, whereas
C-type natriuretic peptide (CNP) binds practically selec-
tively to NPR-B [27, 28]. The clearance receptor binds all
NPs with similar affinity [29].
Results of quantification studies on the NPR distribu-
tion show that the NPR-B is the least abundant type of
NP receptor in glomeruli [25, 26]. Also, the biologic role
of its ligand, CNP, is in the kidney less apparent than the
role of other NPs. Originally isolated from porcine brain
[30], CNP is now known to be synthesized in extraneural
tissues, including vascular endothelium [31] and kidney
[32–34]. Expression of both, CNP and its receptor NPR-B
in the kidney, has led some investigators to the conclusion
that CNP may act in a paracrine and autocrine manner
in this organ [32–34]. Presence of the NPR-B receptors
was reported also in human visceral glomerular epithelial
cells [6] but to date, their role has not been recognized.
In our current study, we investigated the effects of
high glucose and mechanical stress on cultured mouse
podocytes with respect to their susceptibility to NPs be-
cause all these factors are involved in development of
diabetic glomerulopathy. We also characterized the CNP-
dependent system in the podocytes, which appears to be
a prominent source of cGMP in these cells.
METHODS
Materials and reagents
ANP was kindly provided by Dr. W.-G. Forssmann
(Institut for Peptide Research, Hannover, Germany).
CNP was from Bachem (Heidelberg, Germany). Sodium
nitroprusside (SNP), papaverine, TRI Reagent, deoxynu-
cleotide triphosphates (dNTPs), D(+)-glucose and man-
nitol were obtained from Sigma (Schnelldorf, Germany).
HS-142-1, a nonpeptide NP antagonist of microbial ori-
gin, was a kind gift from Kyowa Hakko (Kogyo Co.
Ltd., Japan). Oligonucleotide primers specific for NPR-B
and CNP were synthesized by Eurogentec (Seraing,
Belgium). Taq DNA polymerase was purchased from
Eppendorf AG (Hamburg, Germany). MuLV reverse
transcriptase and RNase inhibitor were from Roche
Molecular Systems (Branchburg, NJ, USA). Cell cul-
ture medium RPMI 1640, fetal bovine serum (FBS),
phosphate-buffered saline (PBS), Dulbecco’s free of
Ca2+ and Mg2+, recombinant c-interferon (c-INF),
penicillin-streptomycin solution, and deoxyribonuclease
were from Life Technologies (Karlsruhe, Germany); col-
lagen I was from Biochrom (Berlin, Germany); trypsin
was from Eurobio (Les Ulis, France); and restriction
enzymes were from MBI Fermentas GmbH (St. Leon-
Rot, Germany). cGMP enzymatic immunoassay (EIA)
set was purchased from Amersham Pharmacia Biotech
(Freiburg, Germany). Mechanical stress-inducing ap-
paratus was built by StretchCo (Edingen, Germany).
Culture plates with flexible bottom were from Bioflex,
Flexcell International (Hillsborough, NC, USA).
Cell culture
Mouse podocytes from a conditionally immortalized
cell line were cultured, as described previously [18].
Briefly, the cells were grown in RPMI 1640 medium
supplemented with 10% FBS, 100 U/mL penicillin, and
100 lg/mL streptomycin in humified atmosphere with
5% CO2. To propagate podocytes, the culture medium
was supplemented with 10 U/mL mouse recombinant
c-INF and the cells were cultivated at 33◦C to enhance
the expression of the temperature-sensitive large T anti-
gen (permissive conditions). To induce differentiation,
podocytes were maintained at 37◦C, without c-INF (non-
permissive conditions) for 1 week before starting the
experiments. For stretching, cells were grown in 6-well
plates, 35 × 103 cells/well. All other experiments were
performed in 48-well plates, with 9 × 103 cells/well. Cells
between passages 10 and 18 were used in all experiments.
Stimulation of cGMP synthesis
One hour prior to stimulation, culture media were re-
placed by serum-free RPMI 1640, containing 0.2 mmol/L
papaverine, a nonselective phosphodiesterase (PDE) in-
hibitor. ANP and CNP in indicated concentrations or
100 lmol/L SNP were added to the wells and podocytes
were incubated at 37◦C for the next 15 minutes. In exper-
iments with NPR antagonist, HS-142-1, was added to-
gether with CNP to the incubation medium. Basal cGMP
level was checked in the wells to which a correspond-
ing volume of incubation medium without activators was
added. Reaction was terminated by adding 10% (vol/vol)
ice-cold lysis buffer A from cGMP EIA kit. After 30 min-
utes of extraction on ice, the supernatant was collected
to the Eppendorf tubes and stored at −20◦C until cGMP
assay.
Exposure to the high concentration of glucose and
application of mechanical stress
Differentiated podocytes were seeded in 6-well plates
with a flexible bottom coated with collagen I, 4 × 104
cells per well. Each well contained 2 mL standard culture
medium. On the fourth day, directly before starting me-
chanical stressing, the cells were divided into three exper-
imental groups: the group remaining in standard RPMI
1640 (containing 10 mmol/L glucose) served as a normal
glucose control; the high glucose group was exposed to
30 mmol/L D-glucose; and an osmotic control group was
cultured in the medium containing 10 mmol/L glucose
and 20 mmol/L mannitol. For experiments comparing
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effects of ANP, CNP, and SNP, all cells remained in the
standard culture medium.
Mechanical stress experiments were performed as de-
scribed before [18]. In brief, the plates were mounted in
the apparatus inducing cyclic (0.5 Hz) air pressure vari-
ations under the membranes and thus, causing their up-
and downward motion, equal to 5% maximal linear cell
strain. Mechanical stress was applied for 3 days. The cul-
ture media were exchanged daily and the cell shape was
checked under the light microscope. Control cells were
cultivated in an identical manner, but were not subjected
to mechanical stress.
cGMP and protein determination
cGMP was determined using the acetylation method in
a cGMP immunoassay system as described in the manual
provided by the manufacturer.
For protein measurement, the cells were rinsed twice
with PBS and solubilized in 500 lL solution of 0.01%
sodium dodecyl sulphate (SDS) in 0.01 N NaOH. The
50 lL aliquots were used for assay by the modified
Bradford method [35]. Measurements were performed
in duplicate.
RNA isolation and reverse transcription
Total RNA was extracted from the cultured cells using
a modified guanidinium isothiocyanate method [36] and
treated with DNase for 15 minutes at room temperature.
DNase was inactivated by heating to 65◦C for 10 minutes.
One microgram total RNA from each sample was incu-
bated at 37◦C for 60 minutes in 20 lL reverse transcription
mixture containing 10 pmol antisense primer, 2.5 U/lL
MuLV reverse transcriptase, 50 mmol/L KCl, 10 mmol/L
Tris-HCl, pH 8.3, 1.5 mmol/L MgCl2, 0.5 mmol/L dNTPs,
and 0.5 U/lL RNase inhibitor. The reverse transcriptase
was inactivated by heating for 10 minutes at 94◦C.
Polymerase chain reaction
On the basis of nucleotide sequence for rat NPR-
B mRNA (GeneBank accession number M26896) and
partial sequence for mouse NPR-B mRNA (GeneBank
accession number AF041211), oligonucleotide primers
were designed for the sequence fragment matching both
species. The primer sequences were as follows: NPR-B
primer 1 (sense) 5
′
-TGTACCATGACCCCGACCTT-3
′
(bases 338-357 in rat sequence), NPR-B primer 2 (an-
tisense) 5
′
-CCCGTTGGCTCTGATGAAGT-3
′
(bases
697-716 in rat sequence). The predicted product size was
398 bp. The mouse CNP-specific primers were designed
based on a published gene sequence (GeneBank acces-
sion number D28873) to span a 394 bp genomic intron.
Primer sequences were: CNP primer 1 (sense) 5
′
-CTCG
CTCCGGCCCTCGAAG-3
′
(bases 1131-1150) and CNP
primer 2 (antisense) 5
′
-AGCCTTTGGACAAGCCCTT
CTT-3
′
(bases 1784-1805). The predicted product size was
302 bp. Reverse transcription (RT) and polymerase chain
reaction (PCR) of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) served as the positive control. The
primers (GeneBank accession number NM 008084) were
GAPDH primer 1 (sense) 5
′
-GTGAAGGTCGGTGTG
AACGGATTTG-3
′
(bases 50-74) and GAPDH primer
2 (antisense) 5
′
-ACATTGGGGGTAGGAACACGGA
AGG-3
′
(bases 711-735). The product length was 710 bp.
For NPR-B cDNA amplification, the PCR master mix
contained PCR buffer diluted 1/10 to have a final com-
position of 50 mmol/L KCl, 10 mmol/L Tris-HCl, pH 8.3,
and 1.5 mmol/L MgCl2, 10 pmol of sense primer and 2.5
U of Taq polymerase. Eighty microliters of a PCR master
mix was added to each tube containing 20 lL of reverse
transcription product and the sample was heated to 94◦C
for 4 minutes (initial melt). This was followed by 35 cy-
cles of the following sequential steps: 94◦C for 1 minute
(melting); 63◦C for 1 minute (annealing); and 72◦C for
2 minutes (extending). The last incubation was at 72◦C
for 8 minutes (final extension). The CNP cDNA amplifi-
cation was carried out with a final concentration of MgCl2
3.5 mmol/L. PCR was performed with “hot start,” fol-
lowed by 40 cycles, with an annealing temperature 69◦C.
To identify amplified products, 12 lL PCR mixture was
added to 3 lL gel loading solution and electrophoresed
in a 100 V constant voltage field in 1% agarose gel con-
taining ethidium bromide.
To confirm the identity of the amplification product, re-
striction analysis was performed with the use of MunI and
PstI for NPR-B and with BSP681 and PauI for CNP am-
plicon. 8 lL of each amplicon was incubated for 2 hours
at 37◦C with 10 U of enzyme in the appropriate buffer
(diluted 1/10) supplied by the manufacturer.
Statistics
Data presented are means ± SE from at least three
experiments. The statistical significance of differences in
results was evaluated by analysis of variances, and mul-
tiple comparisons were performed with the use of the
Student-Newman-Keul’s test. Differences were consid-
ered significant at P < 0.05.
RESULTS
Characterization of the guanylyl cyclase–coupled
receptors in podocytes
Stimulation with ANP, CNP, and SNP. We first exam-
ined the effect of NPs, ANP and CNP, and nitric oxide
donor, SNP, on cGMP synthesis in podocytes. As indi-
cated in Figure 1A, the addition of particulate guanylyl
cyclase agonists CNP or ANP (both 0.1 lmol/L) caused
a significant rise in cGMP (69.0 ± 12.5 and 25.6 ± 4.2,
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Fig. 1. Cyclic guanosine 5
′
monophosphate (cGMP) response of
podocytes. (A) Atrial natriuretic peptide (ANP), C-type natriuretic
peptide (CNP) (both 0.1 lmol/L), and 100 lmol/L sodium nitroprus-
side (SNP). Mean ± SE of eight values (four experiments). ∗P < 0.05
vs. basal (nonstimulated cells); #P < 0.05 vs. ANP. (B) cGMP response
of podocytes stimulated with increasing concentrations of CNP. Mean ±
SE of six values (three experiments). ∗P < 0.05 vs. basal (nonstimulated
cells).
respectively, vs. 5.6 ± 1.4 pmol cGMP/mg protein in the
control) (P < 0.05). Interestingly, the response to CNP
was twofold higher than to ANP and, therefore, in our
further investigations we focused on CNP. Subsequent ex-
periments showed that the cGMP response of podocytes
to CNP was dose-dependent (Fig. 1B). In contrast, a sol-
uble guanylyl cyclase agonist SNP was ineffective at stim-
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Fig. 2. Effect of natriuretic peptide receptor-B (NPR-B) antagonist
HS-142-1 (100 lg/mL) on cyclic guanosine 5
′
monophosphate (cGMP)
synthesis. (A) Effect in the presence of increasing concentrations of C-
type natriuretic peptide (CNP). Mean ± SE of six values (three experi-
ments). ∗P < 0.05 vs. basal; #P < 0.05 vs. CNP alone. (B) Concentration-
dependent inhibitory effect of HS-142-1 on cGMP synthesized in re-
sponse to 0.1 lmol/L CNP. Mean ± SE of six values (three experiments).
∗P < 0.05 vs. CNP alone.
ulating cGMP production. These results suggest that in
cultured mouse podocytes, cGMP synthesis may be due
to stimulation of a particulate, but not soluble form of
guanylyl cyclase. Moreover, the B-type NPR seems to
play a prominent role in this process.
Inhibition of NPR-B by HS-142-1. To further in-
vestigate whether the CNP-induced cGMP increase is
receptor-dependent, we stimulated the podocytes with
increasing concentrations of CNP in the presence of HS-
142-1, a specific NPR-A and -B antagonist [37]. Figure 2A
shows that with 100 lg/mL HS-142-1, the cGMP-
stimulating effect of CNP was almost completely abol-
ished. Only at the highest CNP concentration, 1 lM,
a significant, nevertheless moderate increase in cGMP
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Fig. 3. Representative reverse transcription-polymerase chain reac-
tion (RT-PCR) analysis of mRNA expression for the natriuretic pep-
tide receptor (NPR-B) and C-type natriuretic peptide (CNP) in mouse
podocytes. (A) Step ladder (lane 1); transcripts corresponding to NPR-
B from three separate amplifications, 398 bp (lanes 2 to 4); and product
of amplification in the absence of reverse transcriptase (lane 5). (B) Step
ladder (lane 1); transcript corresponding to CNP from mouse kidney
302 bp (lane 2); transcripts corresponding to CNP in podocytes from
three separate amplifications (lanes 3 to 5); and product of amplification
in the absence of reverse transcriptase (lane 6).
was observed. HS-142-1 suppressed the CNP-induced
cGMP production in a dose-dependent manner (Fig. 2B),
whereas no effect on basal cGMP levels was observed.
Expression of NPR-B and CNP mRNA in podocytes
With RT-PCR, we detected a clear single band that
was of a predicted size of 398 bp for NPR-B (Fig. 3A)
and a clear single band that was of a predicted size of
302 bp for CNP (Fig. 3B). When the PCR procedure was
carried out in the absence of reverse transcriptase, no rec-
ognizable band was seen. This indicated that the 398 bp
and 302 bp bands originated from mRNA, and not from
genomic DNA. Digestion of the RT-PCR products with
restriction enzymes yielded fragments of predicted sizes
233 and 165 bp for NPR-B treated with MunI, and 72 and
326 bp for NPR-B treated with PstI. For CNP treated
with Bsp681, fragments of 146 and 156 bp were obtained,
whereas treatment with PauI yielded 235 and 67 bp frag-
ments. These results coincided with the prediction by the
sequence analysis, and therefore confirmed the identity
of the RT-PCR products.
Effect of mechanical stress and glucose on
CNP-dependent cGMP synthesis
To test for possible conditions which may alter the
CNP-induced cGMP synthesis in podocytes, we chose
mechanical stress and high glucose, since both factors are
known to affect diabetic glomeruli. Indeed, as shown in
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Fig. 4. Effect of mechanical stress on cyclic guanosine 5
′
monophos-
phate (cGMP) formation in podocytes stimulated with atrial natriuretic
peptide (ANP), C-type natriuretic peptide (CNP) (both 0.1 lmol/L),
and 100 lmol/L sodium nitroprusside (SNP). Mean ± SE of five to 11
values (five to 11 separate experiments). ∗P < 0.05 vs. basal (nonstim-
ulated cells); #P < 0.05 stretch vs. control; $P < 0.05 CNP vs. ANP.
Figure 4, in podocytes exposed to mechanical stress for
3 days, response to NPs was markedly blunted as com-
pared to the nonstretched cells. The CNP-stimulated
cGMP decreased by half in the stretched cells (492 ±
72 vs. 1013 ± 89 pmol cGMP/mg protein, stretch vs. con-
trol) (P < 0.05), whereas response to ANP dropped even
more, reaching 37% of the control level (33 ± 11 vs. 90 ±
31 pmol cGMP/mg protein, stretch vs. control) (P < 0.05).
Despite the profound reduction in response to both pep-
tides, markedly higher levels of cGMP induced by CNP
than by ANP were preserved in the mechanical stress
conditions. However, basal cGMP production was not
affected by mechanical stress. SNP failed to stimulate
cGMP production in stretched podocytes as well, indi-
cating that cyclic strain did not induce soluble guanylyl
cyclase activity in these cells.
There was discrepancy between the levels of cGMP
measured upon stimulation with NPs in podocytes seeded
with high (9 × 103 cells/cm2, 48-well plates) and low
(3.6 × 103 cells/cm2, 6-well plates with flexible bottom)
density. In the high-density plates, the cGMP formation
was lower than in the low-density wells (Figs. 1 and 4). In
addition, despite the collagen covering, different struc-
tures of the plastic and silicone bottoms of the culture
plates could also contribute to different degrees of cGMP
synthesis in podocytes. Nevertheless, in both conditions,
a markedly higher cGMP response to CNP was observed
than to ANP.
In podocytes exposed to 30 mmol/L glucose (high glu-
cose) for 3 days, the CNP-stimulated cGMP synthesis was
twofold higher than in the cells cultured in the normal
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Fig. 5. Effect of high glucose (HG), 30 mmol/L, and mechanical
stress on C-type natriuretic peptide (CNP)-stimulated increase in cyclic
guanosine 5
′
monophosphate (cGMP) level. Mean ± SE of five to 11
values (five to 11 separate experiments). ∗P < 0.05 high glucose vs.
normal, 10 mmol/L glucose [normal glucose (NG)] and vs. 10 mmol/L
glucose with 20 mmol/L mannitol (Mann); #P < 0.01 stretch vs. control.
glucose medium (P < 0.05) (Fig. 5). The effect was not
due to the high osmolality because the cells cultivated in
10 mmol/L glucose with 20 mmol/L mannitol responded
to CNP similarly to the cells cultured in the NG. As in
the NG group, mechanical stress reduced the cGMP for-
mation by 50% not only in the mannitol group but also
in the high glucose group (991 ± 128 vs. 1972 ± 207 pmol
cGMP/mg protein, stretch vs. control) (P < 0.01). Thus,
the resulting cGMP response to stimulation with CNP in
podocytes simultaneously exposed to high glucose and
mechanical stress was similar to that in the nonstretched
cells remaining in a normal glucose medium.
DISCUSSION
The present data demonstrate for the first time that in
podocytes exposed to mechanical stress, the cGMP re-
sponse to NPs profoundly decreases, whereas under high
glucose conditions, the cGMP production increases. We
show also that NPR-B is expressed in these cells, which
is accompanied by a significant cGMP response to CNP,
indicating the development of a functionally active recep-
tor. Moreover, the cultured mouse podocytes also express
the mRNA transcript for CNP.
Our major finding was that high glucose and mechani-
cal stress, both factors of relevance in diabetic glomeruli,
altered the CNP-induced cGMP production in an oppo-
site manner. The NPR-B–related signaling was altered in
conditions simulating diabetes, since high concentration
of ambient glucose augmented the CNP-stimulated syn-
thesis of cGMP (Fig. 5). It has been well documented that
a hyperglycemic milieu modifies expression of numerous
proteins [38]. Thus, in podocytes, high glucose could trig-
ger up-regulation of NPR-B and/or down-regulation of
clearance receptors NPR-C, as was described for hyper-
glycemic rats [39]. Another possibility is that in the high
glucose conditions, particulate guanylyl cyclase has been
activated, as was suggested for the mesangial cells [40].
In vivo in diabetic rats, increased renal CNP mRNA and
urinary CNP [41] as well as cGMP [13] excretion were
observed. Our results suggest that the NPR-B receptor
in podocytes may participate in the glucose-dependent
rise in renal cGMP production.
We measured the cGMP response to ANP and CNP in
podocytes subjected to stretching in conditions inducing
complete rearrangement of the actin cytoskeleton [18].
Under these conditions, production of cGMP decreased
by half, both in the presence of CNP and ANP (Fig. 4).
Since mechanical stress affects the gene expression of nu-
merous proteins [19, 20, 42, 43], it could be possible that in
the podocytes, stretching either directly down-regulated
both NPR-A and NPR-B receptors or up-regulated the
clearance receptors NPR-C. Mechanical stress could also
increase expression and/or activity of neutral endopep-
tidase 24.11 (NEP) or form of phosphodiesterase resis-
tant to the inhibitor used by us. Thus, further studies are
required to elucidate mechanism(s) responsible for the
stretch-induced decrease of cGMP generation in the pres-
ence of NPs.
The effect of simultaneous application of mechanical
stress and high glucose to podocytes was resultant of both
these counteracting factors (Fig. 5). Increased by high glu-
cose cGMP response to CNP was reduced by stretching
and in consequence, the level of generated cGMP was
similar to that in the nonstretched cells remaining in nor-
mal glucose. However, in a diabetic kidney, the NP system
has been described to be either up- [13, 41, 44] or down-
regulated [45, 46]. The diversity of obtained results could
be, at least partly, due to the diversity of examined renal
cell types [44–46] in which a diabetic state could evoke
distinct responses. On the other hand, applied by us, a 72-
hour period of exposition of the cells to hyperglycemia
and mechanical stress is a relatively short time, as com-
pared to the at least 14-day duration of the diabetes in-
duced in investigated rats [13, 41, 45]. Thus, the balanced
cGMP synthesis in the presence of counteracting factors
observed in podocytes may reflect an early response to
diabetic conditions.
In the intact glomeruli, the CNP mRNA [33] as well as
immunoreactivity for its receptor NPR-B [47] were found
previously. Additionally, mRNA for NPR-B was detected
in cultured visceral epithelial cells [6]. We, in turn, have
shown that in the defined podocyte cell line, CNP is ex-
pressed together with its receptor NPR-B. Our results
confirm the presence of NPR-B in cultured podocytes
not only by detection of the gene transcript by RT-PCR
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amplification (Fig. 3), but also by functional activity. The
receptor was stimulated by exogenous CNP and inhib-
ited by a specific NPR antagonist in a dose-dependent
manner (Figs. 1B and 2). Apart from NPR-B, also A- and
C-type receptors for NPs were identified in podocytes
[6]. However, the B-type receptor has been reported as
the least abundant of all three NP receptors, not only in
the whole kidney [24] but also in the glomeruli [25, 26].
Furthermore, its ligand, CNP, has been suggested to pref-
erentially act as a paracrine hormone, exerting weaker re-
nal [48] and glomerular [49] effects as compared to ANP.
Nevertheless, in podocytes, unlike in other glomerular
cells, the NPR-B receptor seems to be particularly po-
tent. This could be confirmed by our observation that
stimulation of podocytes with CNP resulted in a twofold
higher cGMP synthesis than with ANP (Fig. 1A). More-
over, in mechanically stressed cells in which a marked
decrease of response to both NPs was observed, the
CNP-dependent cGMP generation was still prevailing
and extended 15-fold the effect of ANP (Fig. 4). This
observation suggests that despite low activity in to-
tal glomeruli, the CNP-dependent system in podocytes
might be the major source of generated cGMP. This ef-
fect could be due either to a higher NPR-B expression
than in other cells, or to an increased activity and/or sen-
sitivity of these receptors.
We have demonstrated that cultured mouse podocytes
express the CNP gene, which makes it likely that these
cells might be a site of the CNP production. Taking into
account the coexpression of NPR-B receptors, it is tempt-
ing to speculate that in podocytes, locally formed CNP
might act in an autocrine manner, as it has been proposed
for some other nephron segments [32–34]. Furthermore,
podocytes may also be a target for CNP released from
neighboring vascular endothelial cells [31]. Yet, despite
the presence of all three receptor types, the role of NPs
and cGMP in podocytes is not clear [50]. Ardaillou et
al [5] and Zhao et al [6] suggested that cGMP produced
in podocytes is released into the Bowman’s space to act
downstream in the nephron, whereas Sharma et al [51]
have demonstrated that cGMP reorganized the actin fila-
ments in rat glomerular epithelial cells. Nevertheless, as-
sociation of this effect with the function of the podocyte
remains to be elucidated.
Incubation of podocytes with high concentration of
SNP, a nitric oxide donor, failed to stimulate the solu-
ble form of guanylyl cyclase both in the control and in the
stretched cells (Figs. 1A and 5). In contrast, in cultured rat
podocytes, the cGMP response to SNP and to S-nitroso-
N-acetyl penicillamine, another nitric oxide donor, was
comparable with that observed with ANP [52]. However,
as reported recently, mouse podocytes seem to be de-
prived of soluble guanylyl cyclase activity [52, 53], which
might be related to some differences between the two
species.
CONCLUSION
This study shows that in podocytes, high glucose en-
hances and mechanical stress inhibits the NP-dependent
cGMP production. Application of the in vitro model has
allowed us to separate the effects of the two major factors
affecting cells in diabetic glomeruli and to reveal their op-
posing action with respect to NP-induced cGMP synthe-
sis. When combined, both these factors seem to balance
their influence on cGMP formation in podocytes, at least
in conditions simulating early diabetes. Demonstration
of functionally active NPR-B receptors in podocytes to-
gether with the CNP gene supports the hypothesis that
CNP may act in an autocrine manner in these cells.
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